|
|||||
|
|
| 阿立派唑在躁郁症治疗中作为增效剂的优势 | |
| 引用本文： | 戴艺荣,翁晋忠. 阿立派唑在躁郁症治疗中作为增效剂的优势[J]. 中国卫生产业, 2014, 0(7): 12-13 |
| 作者姓名： | 戴艺荣 翁晋忠 |
| 作者单位： | 福建省南安市康复院精神科,福建南安362300 |
| 摘 要： | 目的研究阿立派唑在躁郁症治疗中作为增效剂的优势。方法将2011年1月-2012年12月期间我院收治的躁郁症抑郁发作的患者纳入研究，随机分为给予碳酸锂联合阿立派唑治疗的观察组和碳酸锂联合富马酸喹硫平治疗的对照组。观察治疗前和治疗后2周、4周、6周和8周时的HAMD抑郁评分。结果治疗前，两组患者HAMD评分的差异无统计学意义，治疗后两组患者的RA-MD评分均低于治疗前，且观察组患者的HAMD评分低于对照组。结论阿立派唑作为增效剂治疗躁郁症有助于控制抑郁情绪，具有积极的临床价值。 |
| 关 键 词： | 躁郁症 阿立派唑 增效剂 |
Advantages of aripiprazole as synergist in the treatment of bipolar disorder |
|
| DAI Yirong,WENG Jinzhong. Advantages of aripiprazole as synergist in the treatment of bipolar disorder[J]. China Health Industry, 2014, 0(7): 12-13 | |
| Authors: | DAI Yirong WENG Jinzhong |
| Affiliation: | (Psychiatric department, rehabilitation hospital, Nanan city, Fujian Province, Fujian 362300, China) |
| Abstract: | Objective To study the advantages of aripiprazole as synergist in the treatment of bipolar disorder. Methods Bipolar disorder patients in our hospital from January 2011 to December 2012 were enrolled and randomly divided into observation group given lithium carbonate combined with afipiprazole and control group given lithium carbonate combined with quetiapine fumarate. Then before treatment and 2, 4, 6, 8 weeks after treatment, HAMA score were observed.Results Before treatment,there were no significant difference between the two groups of HAMD scores; after treatment, HAMD score were lower than those before treat- ment and HAMA score of observation group were lower than control group.Conclusion Aripiprazole as synergist treatment has pos- itive clinical value for it can control depression emotion. |
| Keywords: | Bipolar disorder Aripiprazole Synergist |
| 本文献已被 CNKI 维普 等数据库收录！ | |